Laxmi Dental has posted a strong set of numbers for the first quarter of FY27. The company saw clear growth in revenue and profit, with its aligners business as the main source of growth. The company also has plans for a new factory in Palghar, Maharashtra, which may support its next phase of expansion.
Laxmi Dental reported consolidated revenue from operations of ₹729.91 million in Q1 FY27. This was higher than ₹643.21 million in Q1 FY26 and marks a growth of 13.6% year on year. Profit before tax rose to ₹120.41 million from ₹95.95 million, a rise of 25.5%.
The company also reported strong growth in profit after tax. The main summary of the result states consolidated net profit at ₹103.15 million, up 23.8% year on year. However, the detailed financial table in the same report shows net profit after tax at ₹95.47 million against ₹73.08 million in Q1 FY26, which is a 30.6% rise. These figures should be checked against the company’s official filing for the final reported PAT number.
Revenue Growth Remains Healthy
The 13.6% rise in revenue is important because it shows that Laxmi Dental has continued to expand despite pressure in one of its main businesses.
Revenue from operations stood at ₹729.91 million in Q1 FY27, compared with ₹643.21 million in the same quarter last year. The rise shows that the company has been able to grow its overall business base.
Profit before tax grew at a faster rate than revenue. It rose 25.5% to ₹120.41 million from ₹95.95 million. This is a positive sign because it means profit growth was stronger than sales growth.
Other income also helped the overall result. Other income stood at ₹22.98 million in Q1 FY27, compared with ₹17.22 million in Q1 FY26.
At the same time, total expenses rose to ₹649.53 million from ₹577.24 million. The rise was mainly due to higher employee benefit costs and higher purchases of stock in trade.
Aligners Business Becomes the Key Growth Driver
The biggest positive part of the result is the performance of the aligners business.
Laxmi Dental’s aligners revenue rose 29.1% year on year to ₹241.69 million from ₹187.26 million. This was much faster than the company’s overall revenue growth.
The aligners business also saw a very sharp rise in its segment result. Segment profit rose to ₹65.33 million from ₹22.79 million in Q1 FY26.
This means the segment result almost tripled in one year. Such a rise is important because aligners are becoming a larger part of the company’s business and profit mix.
The numbers suggest that Laxmi Dental is able to gain better scale in this part of the business. As the business grows, its fixed costs can get spread across a larger sales base. This can support better profit margins if the trend continues.
The strong aligner performance is therefore one of the most important points from the Q1 FY27 result.
Laboratory Business Faces Pressure
The picture is not equally strong across all parts of the company.
The laboratory business remains the largest revenue contributor, but its performance was weaker. The report shows laboratory business revenue at ₹502.81 million in Q1 FY27. The segment result stood at ₹76.98 million.
The report also states that laboratory business revenue declined 7.9% year on year, while its segment result fell from ₹101.54 million in the previous year period to ₹76.98 million.
This is an area that investors need to watch closely.
The laboratory business still has a much larger revenue base than the aligners business. So, any weakness in this segment can have a meaningful effect on the company’s total performance.
At the same time, the strong rise in aligners gives Laxmi Dental another source of growth. If the aligners business continues to expand at a faster rate, it could gradually become more important to the company’s total profit.
Other Business Also Sees a Decline
The company’s other business segment also saw a decline during the quarter.
Revenue from other business stood at ₹10.43 million in Q1 FY27, compared with ₹26.17 million in Q1 FY26. The segment result was ₹1.32 million.
This is a much smaller part of the company compared with laboratory products and aligners. As a result, its effect on the total result is limited.
Still, the numbers show that most of the company’s current growth story comes from the aligners segment, while its core laboratory business faces some pressure.
Earnings Per Share Rises
Laxmi Dental also reported a rise in earnings per share.
Basic EPS stood at ₹1.87 in Q1 FY27 compared with ₹1.53 in Q1 FY26. This marks a rise of 22.2%.
A higher EPS is useful for shareholders because it shows that profit on a per-share basis has also improved.
The company also approved the allotment of 59,360 equity shares to eligible employees under the Laxmi Dental Stock Option Scheme 2024. After this allotment, paid-up equity share capital rose from 5,49,62,149 shares to 5,50,21,509 shares.
New Factory Plan in Palghar
Apart from the quarterly numbers, Laxmi Dental has also taken a step toward future capacity expansion.
The Board noted the execution of a Letter of Intent for the proposed purchase of land in Palghar, Maharashtra. The total consideration for the land is ₹6.21 crore.
The company plans to use the land for factory construction and business expansion.
This move could help Laxmi Dental add more production capacity over time. It may also support the company’s plans for higher sales across its product range.
However, the benefit from the new site will take time. Investors should therefore view this as a long-term growth step rather than an immediate boost to Q1 results.
IPO Funds and Capital Use
Laxmi Dental has also shared an update on the use of its IPO funds.
As of June 30, 2026, the company had used ₹779.72 million from its initial public offer proceeds. The total requirement was ₹1,281.70 million.
This left ₹501.98 million unused. The company has kept this amount in fixed deposits with banks for the time being.
Laxmi Dental is also seeking an extension for the use of the remaining IPO proceeds in later periods.
The Board has further reaffirmed the proposed merger of its wholly owned subsidiary Bizdent Devices Private Limited. The merger is still subject to the required statutory approvals.
What Q1 Results Mean for Investors
The Q1 FY27 result gives investors a mixed but largely positive picture.
The strongest point is the aligners business. Revenue rose 29.1%, while its segment result rose from ₹22.79 million to ₹65.33 million. This is a major improvement and shows the potential of this part of the business.
The overall revenue rise of 13.6% is also healthy. Profit before tax grew by 25.5%, which is faster than revenue growth.
The main concern is the laboratory business. It remains the largest part of the company, but its revenue and segment profit face pressure. Investors will want to see whether this is a short-term issue or a longer trend.
The new Palghar land purchase also deserves attention. A new factory can support future growth, but it will require capital and time before it adds to sales and profit.
The Road Ahead
Laxmi Dental enters the rest of FY27 with both opportunities and challenges.
The aligners business gives the company a strong growth engine. Its rapid revenue rise and sharp improvement in segment profit are encouraging signs. If this growth continues, the business could have a larger role in the company’s future profit mix.
The laboratory business is the key area that needs improvement. A recovery in this segment, along with continued growth in aligners, could create a much stronger overall result.
For now, the Q1 numbers show that Laxmi Dental has maintained revenue growth and achieved a better profit performance. The next few quarters will show whether the company can turn this progress into a steady long-term trend.
Overall, Laxmi Dental’s Q1 FY27 results offer a positive signal, with aligners at the centre of the growth story. Investors, however, should also keep a close watch on the laboratory business, capital use and the pace at which the new Palghar capacity takes shape.
ALSO READ: JNK India PAT Soars 8.5x to ₹9.6 Crore in Q1 FY27
